Viewing data from:

KIONEX

ANDA

SODIUM POLYSTYRENE SULFONATE | A040028 | ANI PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.3270

per ml

Lowest NADAC/Unit

$0.3270

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
62559035601KIONEX 15 GM/60 ML SUSPENSION	$0.3270	ML	—	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 1 NDC (1 FSS)

Lowest Price

$212.38

Highest Price

$212.38

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
62559-0356-01KIONEX 15GM/60ML SUSP,60ML	$212.38	FSS	ANIP Acquisition Company, d/b/a ANI Pharmaceuticals, Inc.	07/14/2027

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

Medicare Part D Spending

CMS annual spending data for Kionex (2024)

Total Spending

$435K

Total Claims

3,135

Beneficiaries

2,275

Avg Cost/Unit

$0.37

Source: CMS Medicare Part D Spending by Drug (2024). Shows gross drug cost under Part D.

API Supply Chain2 active DMFs

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

PUROLITE LLCSODIUM POLYSTYRENE SULFONATE

DMF 58821985

ION EXCHANGE INDIA LTDSODIUM POLYSTYRENE SULFONATE USP (INDION 254)

DMF 183642005

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 15GM/60ML

0 patents0 exclusivities▴

SUSPENSION;ORAL, RECTAL | Approved: Sep 17, 2007

No patent or exclusivity listings for this strength.